Computerized EEG: predictor of outcome in schizophrenia.
Based on a double blind cross-over study, it was determined that schizophrenic patient who have more high frequency fast activity and a lesser degree of alpha and slow waves in computerized EEG before the treatment have a better therapeutic outcome to the major tranquilizer (neuroleptic) treatment. The correlation between pretreatment high frequency computer EEG measurements and better therapeutic outcome reached the level of statistical significance. "Therapy resistant" schizophrenic patients were characterized by a lesser degree of very fast beta activity, more alpha waves and slow waves, higher amplitudes in computer EEG, and a lesser degree of acute (florid) psychotic symptomatology but more "negative" symptoms such as motor retardation and blunted affect. One of the most striking results of the study is the finding that schizophrenic patients with certain psychopathological profiles also have similar computer EEG profiles.
D000328:Adult; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003201:Computers; D004351:Drug Resistance; D004569:Electroencephalography; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012562:Schizophrenia, Disorganized / Q000175:diagnosis / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy; D013888:Thiothixene / Q000627:therapeutic use
D010919:Placebos; D013888:Thiothixene; D006220:Haloperidol; D005476:Fluphenazine